sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Dengue Vaccine Market Insights and Forecast to 2026

Global Dengue Vaccine Market Insights and Forecast to 2026

Category : Pharmaceuticals and Healthcare QY Research Pages :116
Published Date : 2020-12-04

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Dengue Vaccine Market with our analysts monitoring the situation across the globe.
Dengue Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dengue Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Dengue Vaccine market is segmented into CYD-TDV DENVax or TAK-003 TetraVax-DV TDENV PIV V180 DNA vaccines Segment by Application, the Dengue Vaccine market is segmented into Government institutions Hospitals NGOs Regional and Country-level Analysis The Dengue Vaccine market is analysed and market size information is provided by regions (countries). The key regions covered in the Dengue Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Dengue Vaccine Market Share Analysis Dengue Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dengue Vaccine business, the date to enter into the Dengue Vaccine market, Dengue Vaccine product introduction, recent developments, etc. The major vendors covered: GlaxoSmithKline Merck Sharp & Dohme Sanofi Takeda Pharmaceuticals GeneOne Life Sciences Medigen Biologics Panacea Biotec Sun Pharmaceutical U.S NIH Vabiotec
1 Study Coverage 1.1 Dengue Vaccine Product Introduction 1.2 Market Segments 1.3 Key Dengue Vaccine Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Dengue Vaccine Market Size Growth Rate by Type 1.4.2 CYD-TDV 1.4.3 DENVax or TAK-003 1.4.4 TetraVax-DV 1.4.5 TDENV PIV 1.4.6 V180 1.4.7 DNA vaccines 1.5 Market by Application 1.5.1 Global Dengue Vaccine Market Size Growth Rate by Application 1.5.2 Government institutions 1.5.3 Hospitals 1.5.4 NGOs 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Dengue Vaccine Market Size, Estimates and Forecasts 2.1.1 Global Dengue Vaccine Revenue 2015-2026 2.1.2 Global Dengue Vaccine Sales 2015-2026 2.2 Global Dengue Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Dengue Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Dengue Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Dengue Vaccine Competitor Landscape by Players 3.1 Dengue Vaccine Sales by Manufacturers 3.1.1 Dengue Vaccine Sales by Manufacturers (2015-2020) 3.1.2 Dengue Vaccine Sales Market Share by Manufacturers (2015-2020) 3.2 Dengue Vaccine Revenue by Manufacturers 3.2.1 Dengue Vaccine Revenue by Manufacturers (2015-2020) 3.2.2 Dengue Vaccine Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Dengue Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Dengue Vaccine Revenue in 2019 3.2.5 Global Dengue Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Dengue Vaccine Price by Manufacturers 3.4 Dengue Vaccine Manufacturing Base Distribution, Product Types 3.4.1 Dengue Vaccine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Dengue Vaccine Product Type 3.4.3 Date of International Manufacturers Enter into Dengue Vaccine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Dengue Vaccine Market Size by Type (2015-2020) 4.1.1 Global Dengue Vaccine Sales by Type (2015-2020) 4.1.2 Global Dengue Vaccine Revenue by Type (2015-2020) 4.1.3 Dengue Vaccine Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Dengue Vaccine Market Size Forecast by Type (2021-2026) 4.2.1 Global Dengue Vaccine Sales Forecast by Type (2021-2026) 4.2.2 Global Dengue Vaccine Revenue Forecast by Type (2021-2026) 4.2.3 Dengue Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Dengue Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Dengue Vaccine Market Size by Application (2015-2020) 5.1.1 Global Dengue Vaccine Sales by Application (2015-2020) 5.1.2 Global Dengue Vaccine Revenue by Application (2015-2020) 5.1.3 Dengue Vaccine Price by Application (2015-2020) 5.2 Dengue Vaccine Market Size Forecast by Application (2021-2026) 5.2.1 Global Dengue Vaccine Sales Forecast by Application (2021-2026) 5.2.2 Global Dengue Vaccine Revenue Forecast by Application (2021-2026) 5.2.3 Global Dengue Vaccine Price Forecast by Application (2021-2026) 6 North America 6.1 North America Dengue Vaccine by Country 6.1.1 North America Dengue Vaccine Sales by Country 6.1.2 North America Dengue Vaccine Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Dengue Vaccine Market Facts & Figures by Type 6.3 North America Dengue Vaccine Market Facts & Figures by Application 7 Europe 7.1 Europe Dengue Vaccine by Country 7.1.1 Europe Dengue Vaccine Sales by Country 7.1.2 Europe Dengue Vaccine Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Dengue Vaccine Market Facts & Figures by Type 7.3 Europe Dengue Vaccine Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Dengue Vaccine by Region 8.1.1 Asia Pacific Dengue Vaccine Sales by Region 8.1.2 Asia Pacific Dengue Vaccine Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Dengue Vaccine Market Facts & Figures by Type 8.3 Asia Pacific Dengue Vaccine Market Facts & Figures by Application 9 Latin America 9.1 Latin America Dengue Vaccine by Country 9.1.1 Latin America Dengue Vaccine Sales by Country 9.1.2 Latin America Dengue Vaccine Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Dengue Vaccine Market Facts & Figures by Type 9.3 Central & South America Dengue Vaccine Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Dengue Vaccine by Country 10.1.1 Middle East and Africa Dengue Vaccine Sales by Country 10.1.2 Middle East and Africa Dengue Vaccine Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Dengue Vaccine Market Facts & Figures by Type 10.3 Middle East and Africa Dengue Vaccine Market Facts & Figures by Application 11 Company Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Corporation Information 11.1.2 GlaxoSmithKline Description and Business Overview 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered 11.1.5 GlaxoSmithKline Related Developments 11.2 Merck Sharp & Dohme 11.2.1 Merck Sharp & Dohme Corporation Information 11.2.2 Merck Sharp & Dohme Description and Business Overview 11.2.3 Merck Sharp & Dohme Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Merck Sharp & Dohme Dengue Vaccine Products Offered 11.2.5 Merck Sharp & Dohme Related Developments 11.3 Sanofi 11.3.1 Sanofi Corporation Information 11.3.2 Sanofi Description and Business Overview 11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Sanofi Dengue Vaccine Products Offered 11.3.5 Sanofi Related Developments 11.4 Takeda Pharmaceuticals 11.4.1 Takeda Pharmaceuticals Corporation Information 11.4.2 Takeda Pharmaceuticals Description and Business Overview 11.4.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Takeda Pharmaceuticals Dengue Vaccine Products Offered 11.4.5 Takeda Pharmaceuticals Related Developments 11.5 GeneOne Life Sciences 11.5.1 GeneOne Life Sciences Corporation Information 11.5.2 GeneOne Life Sciences Description and Business Overview 11.5.3 GeneOne Life Sciences Sales, Revenue and Gross Margin (2015-2020) 11.5.4 GeneOne Life Sciences Dengue Vaccine Products Offered 11.5.5 GeneOne Life Sciences Related Developments 11.6 Medigen Biologics 11.6.1 Medigen Biologics Corporation Information 11.6.2 Medigen Biologics Description and Business Overview 11.6.3 Medigen Biologics Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Medigen Biologics Dengue Vaccine Products Offered 11.6.5 Medigen Biologics Related Developments 11.7 Panacea Biotec 11.7.1 Panacea Biotec Corporation Information 11.7.2 Panacea Biotec Description and Business Overview 11.7.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Panacea Biotec Dengue Vaccine Products Offered 11.7.5 Panacea Biotec Related Developments 11.8 Sun Pharmaceutical 11.8.1 Sun Pharmaceutical Corporation Information 11.8.2 Sun Pharmaceutical Description and Business Overview 11.8.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Sun Pharmaceutical Dengue Vaccine Products Offered 11.8.5 Sun Pharmaceutical Related Developments 11.9 U.S NIH 11.9.1 U.S NIH Corporation Information 11.9.2 U.S NIH Description and Business Overview 11.9.3 U.S NIH Sales, Revenue and Gross Margin (2015-2020) 11.9.4 U.S NIH Dengue Vaccine Products Offered 11.9.5 U.S NIH Related Developments 11.10 Vabiotec 11.10.1 Vabiotec Corporation Information 11.10.2 Vabiotec Description and Business Overview 11.10.3 Vabiotec Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Vabiotec Dengue Vaccine Products Offered 11.10.5 Vabiotec Related Developments 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Corporation Information 11.1.2 GlaxoSmithKline Description and Business Overview 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered 11.1.5 GlaxoSmithKline Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Dengue Vaccine Market Estimates and Projections by Region 12.1.1 Global Dengue Vaccine Sales Forecast by Regions 2021-2026 12.1.2 Global Dengue Vaccine Revenue Forecast by Regions 2021-2026 12.2 North America Dengue Vaccine Market Size Forecast (2021-2026) 12.2.1 North America: Dengue Vaccine Sales Forecast (2021-2026) 12.2.2 North America: Dengue Vaccine Revenue Forecast (2021-2026) 12.2.3 North America: Dengue Vaccine Market Size Forecast by Country (2021-2026) 12.3 Europe Dengue Vaccine Market Size Forecast (2021-2026) 12.3.1 Europe: Dengue Vaccine Sales Forecast (2021-2026) 12.3.2 Europe: Dengue Vaccine Revenue Forecast (2021-2026) 12.3.3 Europe: Dengue Vaccine Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Dengue Vaccine Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Dengue Vaccine Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Dengue Vaccine Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Dengue Vaccine Market Size Forecast by Region (2021-2026) 12.5 Latin America Dengue Vaccine Market Size Forecast (2021-2026) 12.5.1 Latin America: Dengue Vaccine Sales Forecast (2021-2026) 12.5.2 Latin America: Dengue Vaccine Revenue Forecast (2021-2026) 12.5.3 Latin America: Dengue Vaccine Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Dengue Vaccine Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Dengue Vaccine Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Dengue Vaccine Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Dengue Vaccine Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Dengue Vaccine Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Dengue Vaccine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Dengue Vaccine Market Segments Table 2. Ranking of Global Top Dengue Vaccine Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Dengue Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of CYD-TDV Table 5. Major Manufacturers of DENVax or TAK-003 Table 6. Major Manufacturers of TetraVax-DV Table 7. Major Manufacturers of TDENV PIV Table 8. Major Manufacturers of V180 Table 9. Major Manufacturers of DNA vaccines Table 10. Global Dengue Vaccine Market Size Growth Rate by Application 2020-2026 (K Units) Table 11. Global Dengue Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 12. Global Dengue Vaccine Sales by Regions 2015-2020 (K Units) Table 13. Global Dengue Vaccine Sales Market Share by Regions (2015-2020) Table 14. Global Dengue Vaccine Revenue by Regions 2015-2020 (US$ Million) Table 15. Global Dengue Vaccine Sales by Manufacturers (2015-2020) (K Units) Table 16. Global Dengue Vaccine Sales Share by Manufacturers (2015-2020) Table 17. Global Dengue Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 18. Global Dengue Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dengue Vaccine as of 2019) Table 19. Dengue Vaccine Revenue by Manufacturers (2015-2020) (US$ Million) Table 20. Dengue Vaccine Revenue Share by Manufacturers (2015-2020) Table 21. Key Manufacturers Dengue Vaccine Price (2015-2020) (USD/Unit) Table 22. Dengue Vaccine Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Dengue Vaccine Product Type Table 24. Date of International Manufacturers Enter into Dengue Vaccine Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Dengue Vaccine Sales by Type (2015-2020) (K Units) Table 27. Global Dengue Vaccine Sales Share by Type (2015-2020) Table 28. Global Dengue Vaccine Revenue by Type (2015-2020) (US$ Million) Table 29. Global Dengue Vaccine Revenue Share by Type (2015-2020) Table 30. Dengue Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 31. Global Dengue Vaccine Sales by Application (2015-2020) (K Units) Table 32. Global Dengue Vaccine Sales Share by Application (2015-2020) Table 33. North America Dengue Vaccine Sales by Country (2015-2020) (K Units) Table 34. North America Dengue Vaccine Sales Market Share by Country (2015-2020) Table 35. North America Dengue Vaccine Revenue by Country (2015-2020) (US$ Million) Table 36. North America Dengue Vaccine Revenue Market Share by Country (2015-2020) Table 37. North America Dengue Vaccine Sales by Type (2015-2020) (K Units) Table 38. North America Dengue Vaccine Sales Market Share by Type (2015-2020) Table 39. North America Dengue Vaccine Sales by Application (2015-2020) (K Units) Table 40. North America Dengue Vaccine Sales Market Share by Application (2015-2020) Table 41. Europe Dengue Vaccine Sales by Country (2015-2020) (K Units) Table 42. Europe Dengue Vaccine Sales Market Share by Country (2015-2020) Table 43. Europe Dengue Vaccine Revenue by Country (2015-2020) (US$ Million) Table 44. Europe Dengue Vaccine Revenue Market Share by Country (2015-2020) Table 45. Europe Dengue Vaccine Sales by Type (2015-2020) (K Units) Table 46. Europe Dengue Vaccine Sales Market Share by Type (2015-2020) Table 47. Europe Dengue Vaccine Sales by Application (2015-2020) (K Units) Table 48. Europe Dengue Vaccine Sales Market Share by Application (2015-2020) Table 49. Asia Pacific Dengue Vaccine Sales by Region (2015-2020) (K Units) Table 50. Asia Pacific Dengue Vaccine Sales Market Share by Region (2015-2020) Table 51. Asia Pacific Dengue Vaccine Revenue by Region (2015-2020) (US$ Million) Table 52. Asia Pacific Dengue Vaccine Revenue Market Share by Region (2015-2020) Table 53. Asia Pacific Dengue Vaccine Sales by Type (2015-2020) (K Units) Table 54. Asia Pacific Dengue Vaccine Sales Market Share by Type (2015-2020) Table 55. Asia Pacific Dengue Vaccine Sales by Application (2015-2020) (K Units) Table 56. Asia Pacific Dengue Vaccine Sales Market Share by Application (2015-2020) Table 57. Latin America Dengue Vaccine Sales by Country (2015-2020) (K Units) Table 58. Latin America Dengue Vaccine Sales Market Share by Country (2015-2020) Table 59. Latin Americaa Dengue Vaccine Revenue by Country (2015-2020) (US$ Million) Table 60. Latin America Dengue Vaccine Revenue Market Share by Country (2015-2020) Table 61. Latin America Dengue Vaccine Sales by Type (2015-2020) (K Units) Table 62. Latin America Dengue Vaccine Sales Market Share by Type (2015-2020) Table 63. Latin America Dengue Vaccine Sales by Application (2015-2020) (K Units) Table 64. Latin America Dengue Vaccine Sales Market Share by Application (2015-2020) Table 65. Middle East and Africa Dengue Vaccine Sales by Country (2015-2020) (K Units) Table 66. Middle East and Africa Dengue Vaccine Sales Market Share by Country (2015-2020) Table 67. Middle East and Africa Dengue Vaccine Revenue by Country (2015-2020) (US$ Million) Table 68. Middle East and Africa Dengue Vaccine Revenue Market Share by Country (2015-2020) Table 69. Middle East and Africa Dengue Vaccine Sales by Type (2015-2020) (K Units) Table 70. Middle East and Africa Dengue Vaccine Sales Market Share by Type (2015-2020) Table 71. Middle East and Africa Dengue Vaccine Sales by Application (2015-2020) (K Units) Table 72. Middle East and Africa Dengue Vaccine Sales Market Share by Application (2015-2020) Table 73. GlaxoSmithKline Corporation Information Table 74. GlaxoSmithKline Description and Major Businesses Table 75. GlaxoSmithKline Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. GlaxoSmithKline Product Table 77. GlaxoSmithKline Recent Development Table 78. Merck Sharp & Dohme Corporation Information Table 79. Merck Sharp & Dohme Description and Major Businesses Table 80. Merck Sharp & Dohme Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Merck Sharp & Dohme Product Table 82. Merck Sharp & Dohme Recent Development Table 83. Sanofi Corporation Information Table 84. Sanofi Description and Major Businesses Table 85. Sanofi Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. Sanofi Product Table 87. Sanofi Recent Development Table 88. Takeda Pharmaceuticals Corporation Information Table 89. Takeda Pharmaceuticals Description and Major Businesses Table 90. Takeda Pharmaceuticals Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Takeda Pharmaceuticals Product Table 92. Takeda Pharmaceuticals Recent Development Table 93. GeneOne Life Sciences Corporation Information Table 94. GeneOne Life Sciences Description and Major Businesses Table 95. GeneOne Life Sciences Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. GeneOne Life Sciences Product Table 97. GeneOne Life Sciences Recent Development Table 98. Medigen Biologics Corporation Information Table 99. Medigen Biologics Description and Major Businesses Table 100. Medigen Biologics Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 101. Medigen Biologics Product Table 102. Medigen Biologics Recent Development Table 103. Panacea Biotec Corporation Information Table 104. Panacea Biotec Description and Major Businesses Table 105. Panacea Biotec Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 106. Panacea Biotec Product Table 107. Panacea Biotec Recent Development Table 108. Sun Pharmaceutical Corporation Information Table 109. Sun Pharmaceutical Description and Major Businesses Table 110. Sun Pharmaceutical Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 111. Sun Pharmaceutical Product Table 112. Sun Pharmaceutical Recent Development Table 113. U.S NIH Corporation Information Table 114. U.S NIH Description and Major Businesses Table 115. U.S NIH Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 116. U.S NIH Product Table 117. U.S NIH Recent Development Table 118. Vabiotec Corporation Information Table 119. Vabiotec Description and Major Businesses Table 120. Vabiotec Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 121. Vabiotec Product Table 122. Vabiotec Recent Development Table 123. Global Dengue Vaccine Sales Forecast by Regions (2021-2026) (K Units) Table 124. Global Dengue Vaccine Sales Market Share Forecast by Regions (2021-2026) Table 125. Global Dengue Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million) Table 126. Global Dengue Vaccine Revenue Market Share Forecast by Regions (2021-2026) Table 127. North America: Dengue Vaccine Sales Forecast by Country (2021-2026) (K Units) Table 128. North America: Dengue Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 129. Europe: Dengue Vaccine Sales Forecast by Country (2021-2026) (K Units) Table 130. Europe: Dengue Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 131. Asia Pacific: Dengue Vaccine Sales Forecast by Region (2021-2026) (K Units) Table 132. Asia Pacific: Dengue Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) Table 133. Latin America: Dengue Vaccine Sales Forecast by Country (2021-2026) (K Units) Table 134. Latin America: Dengue Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 135. Middle East and Africa: Dengue Vaccine Sales Forecast by Country (2021-2026) (K Units) Table 136. Middle East and Africa: Dengue Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 138. Key Challenges Table 139. Market Risks Table 140. Main Points Interviewed from Key Dengue Vaccine Players Table 141. Dengue Vaccine Customers List Table 142. Dengue Vaccine Distributors List Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Dengue Vaccine Product Picture Figure 2. Global Dengue Vaccine Sales Market Share by Type in 2020 & 2026 Figure 3. CYD-TDV Product Picture Figure 4. DENVax or TAK-003 Product Picture Figure 5. TetraVax-DV Product Picture Figure 6. TDENV PIV Product Picture Figure 7. V180 Product Picture Figure 8. DNA vaccines Product Picture Figure 9. Global Dengue Vaccine Sales Market Share by Application in 2020 & 2026 Figure 10. Government institutions Figure 11. Hospitals Figure 12. NGOs Figure 13. Dengue Vaccine Report Years Considered Figure 14. Global Dengue Vaccine Market Size 2015-2026 (US$ Million) Figure 15. Global Dengue Vaccine Sales 2015-2026 (K Units) Figure 16. Global Dengue Vaccine Market Size Market Share by Region: 2020 Versus 2026 Figure 17. Global Dengue Vaccine Sales Market Share by Region (2015-2020) Figure 18. Global Dengue Vaccine Sales Market Share by Region in 2019 Figure 19. Global Dengue Vaccine Revenue Market Share by Region (2015-2020) Figure 20. Global Dengue Vaccine Revenue Market Share by Region in 2019 Figure 21. Global Dengue Vaccine Sales Share by Manufacturer in 2019 Figure 22. The Top 10 and 5 Players Market Share by Dengue Vaccine Revenue in 2019 Figure 23. Dengue Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 24. Global Dengue Vaccine Sales Market Share by Type (2015-2020) Figure 25. Global Dengue Vaccine Sales Market Share by Type in 2019 Figure 26. Global Dengue Vaccine Revenue Market Share by Type (2015-2020) Figure 27. Global Dengue Vaccine Revenue Market Share by Type in 2019 Figure 28. Global Dengue Vaccine Market Share by Price Range (2015-2020) Figure 29. Global Dengue Vaccine Sales Market Share by Application (2015-2020) Figure 30. Global Dengue Vaccine Sales Market Share by Application in 2019 Figure 31. Global Dengue Vaccine Revenue Market Share by Application (2015-2020) Figure 32. Global Dengue Vaccine Revenue Market Share by Application in 2019 Figure 33. North America Dengue Vaccine Sales Growth Rate 2015-2020 (K Units) Figure 34. North America Dengue Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 35. North America Dengue Vaccine Sales Market Share by Country in 2019 Figure 36. North America Dengue Vaccine Revenue Market Share by Country in 2019 Figure 37. U.S. Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 38. U.S. Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Canada Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 40. Canada Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. North America Dengue Vaccine Market Share by Type in 2019 Figure 42. North America Dengue Vaccine Market Share by Application in 2019 Figure 43. Europe Dengue Vaccine Sales Growth Rate 2015-2020 (K Units) Figure 44. Europe Dengue Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 45. Europe Dengue Vaccine Sales Market Share by Country in 2019 Figure 46. Europe Dengue Vaccine Revenue Market Share by Country in 2019 Figure 47. Germany Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 48. Germany Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. France Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 50. France Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. U.K. Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 52. U.K. Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Italy Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 54. Italy Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Russia Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 56. Russia Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Europe Dengue Vaccine Market Share by Type in 2019 Figure 58. Europe Dengue Vaccine Market Share by Application in 2019 Figure 59. Asia Pacific Dengue Vaccine Sales Growth Rate 2015-2020 (K Units) Figure 60. Asia Pacific Dengue Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Dengue Vaccine Sales Market Share by Region in 2019 Figure 62. Asia Pacific Dengue Vaccine Revenue Market Share by Region in 2019 Figure 63. China Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 64. China Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 66. Japan Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 68. South Korea Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 70. India Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 72. Australia Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 74. Taiwan Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 76. Indonesia Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 78. Thailand Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 80. Malaysia Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 82. Philippines Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 84. Vietnam Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Asia Pacific Dengue Vaccine Market Share by Type in 2019 Figure 86. Asia Pacific Dengue Vaccine Market Share by Application in 2019 Figure 87. Latin America Dengue Vaccine Sales Growth Rate 2015-2020 (K Units) Figure 88. Latin America Dengue Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 89. Latin America Dengue Vaccine Sales Market Share by Country in 2019 Figure 90. Latin America Dengue Vaccine Revenue Market Share by Country in 2019 Figure 91. Mexico Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 92. Mexico Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Brazil Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 94. Brazil Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Argentina Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 96. Argentina Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 97. Latin America Dengue Vaccine Market Share by Type in 2019 Figure 98. Latin America Dengue Vaccine Market Share by Application in 2019 Figure 99. Middle East and Africa Dengue Vaccine Sales Growth Rate 2015-2020 (K Units) Figure 100. Middle East and Africa Dengue Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 101. Middle East and Africa Dengue Vaccine Sales Market Share by Country in 2019 Figure 102. Middle East and Africa Dengue Vaccine Revenue Market Share by Country in 2019 Figure 103. Turkey Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 104. Turkey Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Saudi Arabia Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 106. Saudi Arabia Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. U.A.E Dengue Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 108. U.A.E Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 109. Middle East and Africa Dengue Vaccine Market Share by Type in 2019 Figure 110. Middle East and Africa Dengue Vaccine Market Share by Application in 2019 Figure 111. North America Dengue Vaccine Sales Growth Rate Forecast (2021-2026) (K Units) Figure 112. North America Dengue Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 113. Europe Dengue Vaccine Sales Growth Rate Forecast (2021-2026) (K Units) Figure 114. Europe Dengue Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 115. Asia Pacific Dengue Vaccine Sales Growth Rate Forecast (2021-2026) (K Units) Figure 116. Asia Pacific Dengue Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Latin America Dengue Vaccine Sales Growth Rate Forecast (2021-2026) (K Units) Figure 118. Latin America Dengue Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 119. Middle East and Africa Dengue Vaccine Sales Growth Rate Forecast (2021-2026) (K Units) Figure 120. Middle East and Africa Dengue Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 121. Porter's Five Forces Analysis Figure 122. Channels of Distribution Figure 123. Distributors Profiles Figure 124. Bottom-up and Top-down Approaches for This Report Figure 125. Data Triangulation Figure 126. Key Executives Interviewed

Get Free Sample

Related Reports

Global Dengue Vaccine Market Insights and Forecast to 2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Dengue Vaccine Market Insights and Forecast to 2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Dengue Vaccine Market Insights and Forecast to 2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Dengue Vaccine Market Insights and Forecast to 2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Dengue Vaccine Market Insights and Forecast to 2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)